Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Open Prospective Study of the Effect of SGLT-2 Inhibitor Dapagliflozin on Glycemic Variability in Patients With Diabetes Mellitus Type 2

NCT02719756 is registered in ClinicalTrials.gov with Research Clinical Centre of the Russian Railways, JSC as lead sponsor.

NCT NCT02719756
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02719756 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Open Prospective Study of the Effect of SGLT-2 Inhibitor Dapagliflozin on Glycemic Variability in Patients With Diabetes Mellitus Type 2
Lead sponsor
Research Clinical Centre of the Russian Railways, JSC
Phase
Phase 4
Overall status
Unknown status
Start date
April 30, 2016
Completion date
December 31, 2016
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, hypoglycemic episodes